CD8A and neoplasm: In the context of CD8 + cytotoxic T lymphocytes (CTL) – mediated immune responses, recognition of tumor associated antigen occurs through its presentation via MHC-I molecule on tumor cells and their interaction with T cell receptor (TCR) on the CD8 + T cells 7–9.